Related posts:
- Dr. Ahmad Sajjadi quoted in JAMA on newly approved blood tests UCI Health Neurologist and UCI MIND faculty member, Ahmad Sajjadi, MD, PhD, was quoted in the highly cited Journal of the American Medical Association (JAMA) regarding the changing landscape of diagnostics with the approval of the nee blood test for Alzheimer’s disease. Read the article here. ...
- Changing the conversation about dementia Today in STAT, my colleague and friend, Dr. Jason Karlawish from the University of Pennsylvania Memory Center offers “The way we talk about dementia is about to change completely.” The history of dementia care is less than ideal. Patients struggle to be seen by specialists and many if not most...
- Blocking PILRA Boosts Brain resident Immune Cells and Reduces Alzheimer’s disease Plaque pathology Alzheimer’s disease (AD) involves the buildup of harmful proteins in the brain. Hereditary changes in the brain resident immune cells, called microglia can strongly affect this process. One of the factors that affect the microglia responses to disease, is “Paired immunoglobulin-like type 2 receptor alpha” or PILRA. PILRA normally acts...
